- Published at
- by gurufocus.com
mixed
mixed
Verastem Oncology Names Matthew E. Ros as Chief Operating Officer
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today ann